FDA Commissioner Nominee Heidi Overton Faces Scrutiny Over Mifepristone Regulatory Future

By Julie F. Kay · STAT News · 2026-09-25

According to STAT News, Senate confirmation hearings for Heidi Overton have heightened concerns regarding the future of medication abortion access in the United States. During testimony, the nominee avoided direct answers about the agency’s scientific review of mifepristone, a dr